| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 105.444 | 22.148 | 28.779 | 0 | 0 | - | - | - | - | - |
| Total Income - EUR | 113.857 | 32.547 | 28.880 | 69 | 0 | - | - | - | - | - |
| Total Expenses - EUR | 118.875 | 54.369 | 174.908 | 143.843 | 126.673 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -5.018 | -21.823 | -146.027 | -143.775 | -126.673 | - | - | - | - | - |
| Net Profit/Loss - EUR | -5.019 | -22.497 | -146.892 | -143.775 | -126.673 | - | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
Check the financial reports for the company - Novel Technologies Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 20.447 | 33.859 | 33.203 | - | - | - | - | - |
| Current Assets | 163.529 | 290.279 | 402.080 | 541.478 | 549.654 | - | - | - | - | - |
| Inventories | 34.380 | 35.467 | 34.866 | 120.504 | 136.664 | - | - | - | - | - |
| Receivables | 97.989 | 227.677 | 256.349 | 273.161 | 268.065 | - | - | - | - | - |
| Cash | 31.160 | 27.135 | 110.865 | 147.813 | 144.925 | - | - | - | - | - |
| Shareholders Funds | -12.474 | -34.844 | -181.147 | -321.597 | -442.042 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 176.003 | 326.933 | 605.452 | 898.680 | 1.026.612 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Novel Technologies Center Srl